BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 17382249)

  • 21. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
    Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK
    Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.
    Lemoli RM; Catani L; Talarico S; Loggi E; Gramenzi A; Baccarani U; Fogli M; Grazi GL; Aluigi M; Marzocchi G; Bernardi M; Pinna A; Bresadola F; Baccarani M; Andreone P
    Stem Cells; 2006 Dec; 24(12):2817-25. PubMed ID: 16931769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
    López-Holgado N; Pata C; Villarón E; Sánchez-Guijo F; Alberca M; Martín A; Corral M; Sánchez-Abarca I; Pérez-Simón JA; San Miguel JF; del Cañizo MC
    Haematologica; 2005 Mar; 90(3):353-9. PubMed ID: 15749668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
    Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS
    Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rapid determination of optimal time for peripheral blood stem cell harvest by detecting hematopoietor progenitor cell during mobilization].
    Guo JJ; Wu SY; Chen YL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):570-3. PubMed ID: 16320591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobilization and collection of peripheral blood stem cells: guidelines for blood volume to process, based on CD34-positive blood cell count in adults and children.
    Anguita-Compagnon AT; Dibarrart MT; Palma J; Paredes L; Mosso C; Montalva R; Salas L; Araos D; Delgado I; Majlis A
    Transplant Proc; 2010; 42(1):339-44. PubMed ID: 20172346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
    Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
    Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients.
    Gasová Z; Marinov I; Vodvárková S; Böhmová M; Bhuyian-Ludvíková Z
    Transfus Apher Sci; 2005 Apr; 32(2):167-76. PubMed ID: 15784451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Punturieri M; Moretti S; Dabusti M; Spanedda R; Castoldi G
    Bone Marrow Transplant; 2003 Dec; 32(12):1165-73. PubMed ID: 14647271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
    Han XH; Shi YK; He XH; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors.
    Kawano Y; Takaue Y; Watanabe T; Abe T; Okamoto Y; Iwai A; Iwai T; Watanabe A; Ito E; Makimoto A; Nakagawa R; Watanabe H; Sato J; Suenaga K; Suzuya H; Ohnishi T; Kanamaru S; Kaneko M; Kuroda Y
    Cancer Res; 1999 Jul; 59(14):3321-4. PubMed ID: 10416586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
    Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
    Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
    Watanabe T; Kawano Y; Watanabe A; Takaue Y
    Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
    Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.